Abstract: Ethnomedicine evolved from the traditional use of plant parts for treating various ailments. Historically, most medical breakthroughs have arisen based on the plant sources showing potential for curing many diseases. Even so, the therapeutic power and scientific validation of their modes of action remains unexplored. Sri Lanka being a biodiversity hotspot due to its high endemism and diversity has inspired the search for ethnopharmacological values which may give rise to drug leads or to the discovery of new bioactive compounds. This brief review aims to highlight the global importance of the exploration of traditional medicinal plants, current status and the progress of the studies on Sri Lankan medicinal plants, and the necessity to discover the medicinal value of the Sri Lankan plants.
INTRODUCTION
Because of the manifold biological activities and medicinal potentials of natural products, all human civilizations have amassed know-how and knowledge of their practical uses. For more than 5,000 years, Ayurveda has been practiced to promote wellness in India. From the Sanskrit words ayurs (life) and veda (knowledge), ayurveda originated from Hindu scriptures called the Vedas, and may have influenced Buddhist philosophy, Eastern and Western health care. In ancient Mesopotamia, circa 2600 BC, medicinal plant descriptions were written on clay tablets in cuneiform. About 1,000 plants and plant-derived substances were inscribed in these tablets, such as the oils of Cedrus species (cedar), the resin of Commiphora myrrha (myrrh) and the juice of the poppy seed Papaver somniferum (Newman et al, 2000) . Many of these herbs and formulations are still used today. Such practices seem to have evolved, as shown by the inscriptions in the Egyptian Ebers Papyrus, dating from around 1550 BC, which contains about 800 complex prescriptions and more than 700 natural agents such as Aloe vera (aloe), Boswellia carteri (frankincense) and the oil of castor, Ricinus communis (Zhong and Wan, 1999) . In what appears to be discriptions of curative agents for known disease conditions, the famous Greek physician, Hippocrates of Cos (circa 460-377 BC), collected more than 400 natural agents and described their use in his Corpus Hippocraticum. Here, he refers to melon juice as a laxative, explains the diuretic effect of the juice from Ornithogalum caudatum (squill) and illustrated the use of Atropa belladonna extract as an anesthetic. He also advised using an extract of Veratrum album (white hellebore) as an emetic and how to use olive oil to improve wound healing (Castiglioni, 1985) . Later, Roman physicians expanded on this extensive knowledge and added their own intuitions and experience. Pedanius Dioscorides (circa 40-90 AD) compiled De Materia Medica, which described the dosage and efficacy of about 600 plant-derived medicines which contributed to the development of pharmacology in Europe (Wermuth, 2003) . , another famous Greek physician and pharmacist, recorded 540 plant-derived medicines and demonstrated that herbal extracts contain both beneficial and harmful compounds (Cai, 1992) .
indigenous systems of medicine which use plant based interventions (Anon., 1978) . The 'Ayurveda', 'Deshiya Chikitsa', 'Siddha' and 'Unani' are systems widely practiced in Sri Lanka. Ayurveda and Deshiya Chikitsa systems use plant and herbal products, the former using approximately 2,000 plant species and the latter about 500. Long established preparations like 'arishta', 'kasaya', 'guli' and 'kudu' contain the majority of material derived from plants. 'Sinhalese Materia Medica' is a modern day list of a sizable number of Sri Lankan plants used in the above traditional preparations (Attygalle, 1917) . Later, chemistry and the pharmacology of Sri Lankan and Indian plants was published by Chandrasena (1955) followed by the serial compilation by Jayaweera (1980-82) on medicinal plants used in Sri Lanka.
SRI LANKA'S BIODIVERSITY
Sri Lanka is one of the most biologically diverse countries in Asia. Despite its small size of 6,524,540 hectares, Sri Lanka has a varied climate and topography, which has resulted in rich endemism distributed within a wide range of ecosystems. Its distinctive biological diversity is defined by the ecosystems, species and genera that occur in the island's diverse array of forests, wetlands, coastal, marine and agricultural systems. Sri Lanka's biodiversity is considered to be the richest per unit area in the Asian region with regard to mammals, reptiles, amphibians, fish and flowering plants. The global importance of the island's biodiversity has placed Sri Lanka together with the Western Ghats of India among the 34 biodiversity hotspots in the world (Myers et al., 2000) .
IDENTIFICATION OF FLOWERING PLANTS IN SRI LANKA
The most comprehensive description of Sri Lankan plants was carried out during the Colonial period by Trimen (1893 Trimen ( -1931 and that was subsequently revised by Dassanayake and Fosberg (1980-2000) . This latter attempt has helped to expand and modernize the National Herbarium at the Royal Botanical Garden in Peradeniya which safeguards the authentication of the plants. The National Herbarium currently contains about 165,000 specimens.
Globally, the angiosperms are the most diverse group of plants with an estimated number of 200,000 to 400,000 species (Thorne, 2002) belonging to 415 families. In Sri Lanka, angiosperm flora has been recorded by several scientists since the colonial times. The earliest being Trimen's Handbook to the Flora of Ceylon (Trimen, 1893 (Trimen, -1900 . More recently, the revision of the Trimen's Flora (Dassanayake and Fosberg 1980-2000) described 3,771 species in 1,363 genera and that included many naturalized species. The total number of endemic species (including varieties and subspecies) was about 1,000 according to that revision. Compared to the rest of South Asia, angiosperm diversity in Sri Lanka is remarkably high due to multitudes of factors. Origin, affinities and biogeography of our flowering plants have been discussed by several authors in the past (Trimen, 1893 (Trimen, -1900 Ashton and Gunatilleke, 1987) .
One of the prominent attributes of Sri Lanka's angiosperm flora is its high endemicity. The Red List of Sri Lanka disclosed that there are 894 endemic angiosperm species in Sri Lanka distributed largely in the central and south west region (MOE, 2012) . However, there may be more endemic species in the northeast and eastern areas of the country where the plant species have not undergone botanical descriptions as the plants of south western regions. Sri Lanka has no endemic families although 14 endemic genera have been described. The endemic genera Hortonia (Family: Monimiaceae) and Schumacheria (Family: Dilleniaceae) have probably been derived from the Gondwanaland flora of 100-120 million years ago (Somasekaram et al., 1997) .
The relict rain forest plant taxa of Gondwana-Deccan ancestry are now found only in some isolated forest pockets in the Penninsular India and Southwestern Sri Lanka. Deccan flora evolved in isolation in the late Cretaceous and early Tertiary periods, during the drifting of the Indian plate (Somesekaram et al., 1997) . It has been hypothesized that biotic impoverishment, prior absence followed by colonization and later speciation has led to the tremendous endemic diversity in the island (Biswas, 2008) . It is thus fitting that the World Conservation Monitoring Centre has also designated Sri Lanka as a biodiversity hotspot (Caldecott et al., 1994) .
Out of 3,154 indigenous species evaluated in the Red List, 1,386 (44%) are threatened (critically endangered, endangered or vulnerable). Out of the 186 families evaluated, 81 families have 50% or more threatened species and in 24 families all species are threatened.
Only 45 families do not consist of any threatened species. Out of all these, six species are believed to be extinct viz., Strobilanthes caudata (Acanthaceae), Blumea angustifolia (Asteraceae), Crudia zeylanica (Fabaceae), Rinorea bengalensis and Rinorea decora (Violaceae). Alphonsea hortensis (Annonaceae) and Doona ovalifolia (Dipterocarpaceae). These species are believed to be found only in cultivation at the National Botanic Gardens (extinct in the wild). However, Rinorea bengalensis and Rinorea decora have been rediscovered (MOE, 2012) .
STATUS OF LOWER PLANTS
Our understanding of the diversity of lower plants such as lichens, mosses, liverworts and hornworts has been enhanced with more recent studies.
Brunbauer in 1984 compiled 15 articles based on published literature on Sri Lankan lichens (Brunbauer, 1984 (Brunbauer, -1986 ) which included 550 species belonging to 122 genera and 48 families. According to the literature, 696 lichens had been recorded in 2006. Some recent investigations on lichens carried out in Sri Lanka indicate that the numbers of lichen species recorded from Sri Lanka may exceed 1000 species (Jayalal et al., 2008) ; importantly, a number of new species have been recorded (Orange et al., 2001; Jayalal et al., 2012; Weerakoon et al., 2012 ).
Abewickrama
and Jansen (1978a) published the first checklist of liverworts and hornworts of Sri Lanka, where they reported 183 species of the former and 5 species of the latter. Recently, Long and Rubasinghe (2014) have expanded this list to include 327 species of liverworts and 5 species of hornworts. Abewickrama and Jansen (1978b) also reported 569 species of mosses and high endemicity was noted (11%) among them. A recent study by Ruklani and Rubasinghe (2013) has added 12 new species of mosses.
GLOBAL BIODIVERSITY TREATIES
The United Nations Convention on Biological Diversity (CBD) has resulted from the Rio Earth Summit in 1992 in Brazil . The three main objectives of the CBD are the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of the benefits arising from commercial and other utilization of genetic resources. The agreement covers all ecosystems, species, and genetic resources. It established expectations regarding access to and the use of biodiversity ('genetic resources') across national borders. In general, the CBD states that: (a) countries have sovereign entitlements over the genetic resources within their boundaries, (b) access to genetic resources by foreign groups obliges prior informed agreement from the appropriate authority in the country containing the genetic resource, (c) access on mutually agreed terms should be facilitated by the source country, (d) benefits from the use of genetic resources should be shared in a just and reasonable way with the source country, (e) the source country should participate in related research on the genetic resources, where feasible, and profit from technology transfer. The CBD was signed by most countries in the world (194 to date), including Sri Lanka, and has been extensively ratified (with the important exception of the United States). However, since the CBD necessitates individual countries to adopt appropriate laws and regulations to implement its principles, the impact of the CBD has been mixed. Importantly, the CBD did not offer exclusive recommendations addressing the use of traditional knowledge from one group of people by other groups or companies. This became the subject of the Nagoya Protocol, which was approved in 2010 by the Conference of the Parties to the CBD. This Protocol gives enumerated proposals that cover access and benefit-sharing related to natural products and traditional knowledge. Although the Protocol has been signed by 92 countries (as of November 2014), it is only ratified by 30 countries, with Norway being the first 'developed' nation to do so. Fifty countries have to adopt the Protocol before it can become legal and binding. However, it can be considered as a realistic guide for those working on biodiversity making use of traditional knowledge.
GLOBAL REASSESSMENT OF NATURAL PRODUCTS AS POTENTIAL DRUGS
After several decades of insufficient interest in natural products as drug candidates, today there is a progressively strong case for reevaluating natural products for drug discovery. Traditionally, natural products are a source of almost all medicinal preparations and, more recently, natural products have entered clinical trials or provided lead compounds that have entered clinical trials, mainly as anticancer and antimicrobial agents Dias et al., 2012) . A comprehensive analysis of new medicines approved by the US Food and Drug Administration (FDA) between 1981 and 2010 showed that 34% of those medicines that were founded on small molecules were natural products or direct derivatives of natural products -comprising the statins, tubulin-binding anticancer drugs and immunosuppressants (Mishra and Tiwari, 2011; Carter, 2011; Cragg and Newman, 2013; Butler and Blaskovich, 2013) . Although it seems ironic that despite success stories, there was diminished interest in natural products by the pharmaceutical industry. There have been several reasons for the lack of interests in natural products for drug discovery. There are genuine concerns regarding the United Nations Convention on Biological Diversity which pursues to regulate international access to natural products. The following may be the reasons why natural products became a source of low interest in drug discovery: (a) assumption that natural products are incompatible with drug discovery approaches based on high-throughput screening (HTS) directed at molecular targets (Rishton, 2008) ; (b) unreliability of repeated isolation of known compounds and synthesis of natural products during pharmaceutical manufacture being impractical (Drewry and Macarron, 2010) ; (c) combinatorial chemistry has not provided all the lead compounds needed for effective lead discovery .
However, it is now understood that the diversity within biologically relevant 'chemical space' is more significant than the size of the library of compounds. Natural product libraries show a wide range of pharmacophores rich in stereochemistry, and these attributes are considered important in contributing to their ability to deliver hits, even against proteinprotein interactions which are normally hard to achieve (Drewry and Macarron, 2010) . In addition, natural products have the benefit over synthetic compounds since they are natural metabolites, and importantly, drugs have been implied to show the property of 'metabolitelikeness' (Hert et al., 2009) . This means that they are both biologically active and will act as substrates for one or more of the many transporter systems that can carry the compounds to their intracellular site of action.
Traditionally in natural-product research, concentrated extract samples were screened in bioassays (Quinn, 2012) . Usually, these extracts are complicated mixtures. Although, all components present in the extract may reach the biological target of the assay, the concentration of some components may be too low to have measurable effects. In addition, the signal from the assay may be confused by interference or undesirable compounds, or by the additive or synergistic effects of mixtures of compounds. On the other hand, isolating each and every compound from a crude extract prior to screening is cumbersome, and too costly for large numbers of samples. Thus, the removal of artifacts prior to screening will be very useful: polyphenolic tannins are the usual nuisance compounds in plant extracts (Wall, 1996) . Then, fractions which are less complex can be prepared for screening, allowing the scale to be reduced and the speed increased. The use of simplified fractions, together with sensitive NMR techniques, has tackled the isolation and structure-elucidation bottleneck.
The Dictionary of Natural Products has records of about 200,000 plant secondary metabolites, including about 170,000 unique structures (after the removal of duplicates). Around 15% of the drug interventions in the www.ClinicalTrials.gov database are plantrelated, with approximately 60% of these 'drugs' being grouped from only 10 taxonomic families (Sharma and Sarkar, 2013) . Notwithstanding these hits, it is very likely that the majority of plant species have not been systematically investigated in drug discovery campaigns. In addition, microorganisms exhibit a significance of biodiversity that betters those of eukaryotes, and can have incomparable metabolic adaptability.
The study of metabolomics came about from the goal of qualitatively and quantitatively analyzing all metabolites in an organism within a given time frame and conditions. Metabolomics makes it possible for indirect monitoring of gene function and biochemical status of an organism. Thus, metabolomics and genomics can be used to optimize biosynthetic pathways to selectively produce biologically active natural products (Craig et al., 2010) .
In another approach, metabolomics has enabled the study of the effects of the complex mixtures contained in traditional herbal medicine (Youns et al., 2010) . For example, Angelica sinensis tea-derived Chinese health products have been analyzed by chemometric-guided HPLC to give qualitative analysis on the individual compounds contained in overlapping profiles of co-eluting compounds (Li et al., 2013) .
Metabolomics with electrospray ionization quadrupole time-of-flight mass spectrometry (ESI-TOFMS) led to the isolation of an antitumour saponin from Panax ginseng (Mao et al., 2012) .
Overexpression is a unique method to overcome the supply problems of minor metabolites (Stevens et al., 2013) . Overexpression and antisense-suppression methods have been used in transgenic plants such as soybean where key gene-coding enzymes for flavonoids, isoflavanoids and terpenoids led to circumventing seasonal and geographical limitations (Wang et al., 2011; Lange and Ahkami, 2013) .
SCREENING STUDIES OF NARTURAL PRODUCTS IN SRI LANKA
The Department of Chemistry, University of Peradeniya initiated a research project aimed at chemical investigation of endemic plants of Sri Lanka in 1981, the first such large scale effort in this area. In this project, about 125 Sri Lankan plant species were investigated. Some of these efforts are highlighted in the publications below.
The family Clusiaceae, where several nonendemic species belonging to Calophylum and Garcinia are used in indigenous medicine in Sri Lanka (Attygala, 1917; Chandrasena 1955) , emerged as a family rich in xanthones (Gunasekara et al., 1981; Bandara et al., 1986) .
Among the family Dipterocarpaceae, Sri Lanka has 9 genera, with 58 species of which Doona and Stemonoporus are endemic (Kostermans, 1992) . Almost all species of Dipterocarpaceae are endemic. A large number of sesquiterpenes and triterpenes have been reported from this family (Bandaranayake et al., 1975) .
Another family of high endemism is Flacourtiaceae (now under Achariaceae and Salicaceae). Here, 8 genera and nine species are endemic (Bandaranayake and Sultanbawa, 1969) .
The presence of triterpenoids is the hallmark of this plant family (Gunasekera and Sultanbawa, 1973) .
Two endemic plants of the family Celastraceae, namely Kokoona zeylanica Thw. and Salacia reticulata var. diandra Thw. have been extensively studied in Peradeniya. From the former, among a number of compounds isolated, tri-and tetra-oxygenated D:A-friedo-oleanan triterpenes (Gunatilaka and Nanayakkara, 1984) , 27-hydroxy and 6β-hydroxy di-and trioxygenated D:A-friedo-oleanane triterpenes , phenolic D:A-friedo-24-noroleanane triterpenoids (Gunaherath and Gunatilaka, 1983) are noteworthy. The latter plant, commonly referred to as Kothala Himbutu, is erroneously named as Salacia reticulata var. diandra Thw. Significantly, this plant was first described by Thwaites as Salacia diandra as a distinct species endemic to Sri Lanka and it was later reduced to a variety of S. reticulata (Salacia reticulata var. diandra) by Lawson in 1875. However, in the Revised Handbook to the Flora of Ceylon (Dassanayake and Fosberg, 1980-2000) it has been listed as Salacia diandra Thw. A notable difference in S. diandra from S. reticulata is its solitary flowers, narrower leaves with entire margin and finer reticulation of veins and flowers with two stamens. Unlike S. reticulata, S. diandra is distributed in the Wet Zone (wetter parts of Ratnapura, Galle and Matara Districts). According to the National Red List, S. diandra is an endangered plant. Undoubtedly, this plant which is commonly known to be originating from India and Sri Lanka, is a plant endemic to Sri Lanka.
Following noteworthy attempts at screening endemics for their biological activity stand out: Antimicrobial and insecticidal activities of Sri Lankan plants were carried out by scientists from the University of Peradeniya; of particular importance are the work on endemics (Hewage et al., 1998; Kumar et al., 1989; ; Bandara et al., 2015) . In addition, biological activity of Sri Lankan lichens have also been determined (Thadhani et al., 2012) . Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection were reported by Munasinghe et al., (2001) . Arseculeratne et al., (1985) screened fifty medicinal plants for hepatotoxic activity. In a seminal study of oral hypoglycemic activity of some Sri Lankan plants, Karunanayake et al., (1984) reported the antidiabetic activity of Salacia diandra Thw. Sri Lankan alkaloids and their biological activity have been reviewed by Gunatilaka, (1999) . Siriwardena et al., have reviewed the biologically active compounds isolated from Sri Lankan flora (2015) . The endemic genera, Hortonia and Schumacheria have been extensively studied (Ratnayake et al., 2008; Ratnayake, 2009; Carr, 2012) and (Bandara et al., 2015) . Twelve of the seventeen endemic Annonaceae plants were investigated for their bioactivity and the presence of Alkaloids (Weerasinghe et al., 2013; Puvenendran et al., 2010) . Authors claimed that the remaining five species could not be collected due to their unavailability from the recorded sites, yet again highlighting the importance of investigating the medicinal value of Sri Lankan endemic species before it is too late.
Tropical lichens, particularly ones from Sri Lanka, continue to unfold a wide variety of biologically active phenolic compounds with iron chelating siderophore type activity (Karunaratne et al., 2005; Kathirgamanathar et al., 2006; Karunaratne et al., 2002; Karunaratne et al., 1992) .
Out of the 30 patents covering the compounds and extracts of Salacia reticulata var. diandra (Kothala Himbutu) growing in Sri Lanka and India, several Japanese patents claim anti-diabetic properties of its extracts. The claims of these patents have been made despite the practice of using S. diandra in the treatment of high blood-sugar, which is part of the traditional knowledge of Sri Lanka; and furthermore its efficacy had been shown through work carried out by Karunanayake et al. (1984) prior to the approval of these patents. Although, the group in Peradeniya missed the antidiabetic principals found in the aqueous extract of the root of this plant, they published isolation of quinonemethides (Tezuka et al., 1993; Tezuka et al., 1994; Dhanabalasingham et al., 1996) from the organic extracts of this plant.
More recently, Attanayake et al., (2013) has reported the efficacy and dose response studies of oral antihyperglycaemic activity of eight Sri Lankan medicinal plant extracts, used in the treatment of diabetes in traditional medicine in diabetic rats. Table 1 lists the endemic plants with reported medicinal activity. However, work on the endemic genera Hortonia and Schumacheria have shown that many more endemic plants can be added to this list (Ratnayake et al., 2008; Bandara et al., 2015) .
FUTURE DIRECTIONS AND CONCLUSIONS
Prior to about 1985-2000, biological activity determination of plant derived secondary metabolites were not routinely carried out. Thus, the numerous compounds reported in the above description were not tested for their biological activity.
For example, xanthones and triterpenoids have recently been reported for their antitumour activity (Pinto et al., 2005; Petronelli, 2009 ). Therefore, a strong case can be made for reinvestigating the plants that come under the families such as Guttiferae, Dipterocarpaceae and Celastraceae, particularly the endemic plants, for their biological activity. Thus, in Sri Lanka, since there has not been a large-scale systematic search for therapeutics from its flora so far, the potential of Sri Lankan endemic flowering plants (823) and the nonflowering plants such as lichens remain largely unknown. Therefore, variety, richness and abundance of flora in Sri Lanka in general make it a fertile testing ground for a systematic drug discovery program. (Jayaweera, 1980-82) .
Plant Name Family Medicinal uses
Semecarpus coreacea Thwaites Anacardiaceae Used for scrofulous, venereal and leprous conditions; as a vesicant in rheumatism and sprains; used for piles, boils in the rectum, urinary diseases, nervous debility, skin diseases, sexual debility, and diseases of the liver and spleen; used as a vermifuge and for asthma and cancer.
Semecarpus gardneri Thwaites Anacardiaceae Used for dysentery, asthma, coughs and incipient tuberculosis; used as an emetic. Root with water is used for neuralgia and headache.
Vernonia zeylanica Less Asteraceae Used in bone fractures; leaves applied on suppuration of boils; with turmeric, used for eczema of the legs; leaves used for treatment of asthma, also as an emetic, particularly in cases of food poisoning.
Impatiens repens Moon
Balsaminaceae Used in epilepsy, piles and hemorrhoids.
Canarium zelyanicum Blume Burseraceae Bark is astringent and antiseptic; a decoction is used for bleeding and spongy gums; an ointment is used for chronic ulcers and fistulae; used as an aromatic stomachic and astringent and against diabetes; useful for infective fevers and malaria;gum resin used for halitosis.
Calophyllum walkeri Wight Clusiaceae
Oil from the seeds used on fractures and contusions.
Argyreia populifolia Choisy Convolvulaceae Used as an astringent and antiseptic; leaves used for treating weak and spongy gums; root applied to swellings caused by dog bite.
Dillenia retusa Thunb Dilleniaceae Fruit used for poultices, fractures and dislocations.
Dipterocarpus glandulosus Thwaites
Dipterocarpaceae Resin oil used in rheumatic swellings and leprosy.
Dipterocarpus zeylanicus Thwaites Dipterocarpaceae Heartwood used for fever; gum resin used on chronic ulcers, sinuses and fistulae; it acts as a diaphoretic and expectorant; useful against pharyngitis, tonsillitis, bronchitis and pneumonia.
Sansevieria zeylanica (Linn.) Willd Dracaenaceae
Root used for bile and gonorrhea.
Hydnocarpus venenata Gaertn Flacourtiaceae Oil used as application for cutaneous diseases and for leprosy.
Exacum trinerve (Linn.) Druce Gentianaceae Entire plant used for mild fevers.
Plectranthus zeylanicus Benth Lamiaceae Used for fevers, dysentery, diarrhea, vomiting and thirst; acts as a cholagogue and useful for acute and chronic congestion of the liver; used as a diuretic and diaphoretic.
Litsea longifolia Benth. & Hook. Lauraceae Bark used for treating nervous diseases and boils.
Plant Name Family Medicinal uses

F.
Barringtonia ceylanica (Miers) Gard. Ex C.B. Clarke Lecythidaceae Tender leaves used for dysentery and bleeding from cuts; bark and leaves used for rat-snake bites, rat poisoning and on boils; seeds employed for treatment of itch, piles, tonsillitis and typhoid fever; bark used for gastric ulcers.
Munronia pumila Wight Meliaceae Given for fever, dysentery and purification of blood.
Horsfieldia iryaghedhi (Gaertn.) Warb.
Myristicaceae
Flowers and bark used for dysentery, hiccough and wasting .
Zeuxine regia (Lindl.) Trimen Orchidaceae Used for treating snake-bite poisoning.
Madhuca neriifolia (Thw.) H. J. Lam.
Sapotaceae
Used in skin disease, rheumatism, headache, as a laxative, for piles, hemorrhoids, is an emetic, and anti-earth worm.
Madhuca fulva (Thw.) J.F. Macbr Sapotaceae Leaves and bark are used on scalds and burns.
Amomum masticatorium Thwaites Zingeberaceae Rhizome is aromatic and carminative.
